The moral argument is self-evident and powerful, but improving diversity in the clinical trial patient population and workforce is also the right thing to do from a scientific perspective, says […]
“Whatever we could do to make it easier for patients, we tried to do,” Patrick Floody, senior director of global study strategy and optimization at Regeneron, told attendees of the […]
U.S. Representatives Bobby L. Rush (D-Ill.) and Brian Fitzpatrick (R-Pa.) have introduced the Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act (H.R. 3437), new bipartisan legislation that […]
A five-year community outreach and engagement effort by the Abramson Cancer Center at the University of Pennsylvania (Penn) in Philadelphia to increase enrollment of Black patients into cancer clinical trials […]
Institutions and their investors appear to be banking on continued growth in clinical research—in particular, in terms of decentralized clinical trials (DCTs)—being a healthy trend, if recent announcements of significant […]